Involvement of sirtuin 1 in airway inflammation and hyperresponsiveness of allergic airway disease

Journal of Allergy and Clinical Immunology

Volumn 125, Issue 2, 2010, Pages

  Kim, So Ri ^a   Lee, Kyung Sun ^a   Park, Seoung Ju ^a   Min, Kyung Hoon ^a   Choe, Yeong Hun ^a   Moon, Hee ^a   Yoo, Wan Hee ^a   Chae, Han Jung ^a   Han, Myung Kwan ^a   Lee, Yong Chul ^a  

^a Chonbuk National University Medical School   (South Korea)

Author keywords

Allergic airway disease; histone deacetylase; hypoxia inducible factor 1 ; sirtinol; sirtuin 1; vascular endothelial growth factor

Indexed keywords

2 METHOXYESTRADIOL; 2 MORPHOLINO 8 PHENYLCHROMONE; GAMMA INTERFERON; HYDROLASE INHIBITOR; HYPOXIA INDUCIBLE FACTOR 1ALPHA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 13; INTERLEUKIN 4; INTERLEUKIN 5; OVALBUMIN; SIRTINOL; SIRTUIN 1; VASCULOTROPIN; VASCULOTROPIN INHIBITOR; WORTMANNIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ARTICLE; BLOOD VESSEL PERMEABILITY; CELL INFILTRATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; DISEASE MODEL; ENZYME ASSAY; ENZYME INHIBITION; EPITHELIUM CELL; FEMALE; IMMUNOMODULATION; IMMUNOPATHOGENESIS; INFLAMMATORY CELL; LUNG INFILTRATE; MOUSE; NONHUMAN; PNEUMONIA; PRIORITY JOURNAL; PROTEIN CONTENT; PROTEIN EXPRESSION; RESPIRATORY TRACT ALLERGY; RESPIRATORY TRACT INFLAMMATION; SIGNAL TRANSDUCTION; TISSUE LEVEL; TRACHEA MUCOSA; UPREGULATION;

EID: 75849159982     PISSN: 00916749     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jaci.2009.08.009     Document Type: Article

References (61)

1. Bousquet J., Jeffery P.K., Busse W.W., Johnson M., and Vignola A.M. Asthma. From bronchoconstriction to airways inflammation and remodeling. Am J Respir Crit Care Med 161 (2000) 1720-1745
2. Hamelmann E., Tadeda K., Oshiba A., and Gelfand E.W. Role of IgE in the development of allergic airway inflammation and airway hyperresponsiveness-a murine model. Allergy 54 (1999) 297-305
3. Zhang D.H., Yang L., Cohn L., Parkyn L., Homer R., Ray P., et al. Inhibition of allergic inflammation in a murine model of asthma by expression of a dominant-negative mutant of GATA-3. Immunity 11 (1999) 473-482
4. Foster P.S., Martinez-Moczygemba M., Huston D.P., and Corry D.B. Interleukins-4, -5, and -13: emerging therapeutic targets in allergic disease. Pharmacol Ther 94 (2002) 253-264
5. Hassig C.A., and Schreiber S.L. Nuclear histone acetylases and deacetylases and transcriptional regulation: HATs off to HDACs. Curr Opin Chem Biol 1 (1997) 300-308
6. de Ruijter A.J., van Gennip A.H., Caron H.N., Kemp S., and van Kuilenburg A.B. Histone deacetylases (HDACs): characterization of the classical HDAC family. Biochem J 370 (2003) 737-749
7. Verdin E., Dequiedt F., and Kasler H.G. Class II histone deacetylases: versatile regulators. Trends Genet 19 (2003) 286-293
8. Hisahara S., Chiba S., Matsumoto H., and Horio Y. Transcriptional regulation of neuronal genes and its effect on neural functions: NAD-dependent histone deacetylase SIRT1 (Sir2alpha). J Pharmacol Sci 98 (2005) 200-204
9. Yang S.R., Wright J., Bauter M., Seweryniak K., Kode A., and Rahman I. Sirtuin regulates cigarette smoke-induced proinflammatory mediator release via RelA/p65 NF-κB in macrophages in vitro and in rat lungs in vivo: implications for chronic inflammation and aging. Am J Physiol Lung Cell Mol Physiol 292 (2007) L567-L576
10. Yang T., Fu M., Pestell R., and Sauve A.A. SIRT1 and endocrine signaling. Trends Endocrinol Metab 17 (2006) 186-191
11. Lee Y.M., Kim S.H., Kim H.S., Son M.J., Nakajima H., Kwon H.J., et al. Inhibition of hypoxia-induced angiogenesis by FK228, a specific histone deacetylase inhibitor, via suppression of HIF-1alpha activity. Biochem Biophys Res Commun 300 (2003) 241-246
12. Rane S., He M., Sayed D., Vashistha H., Malhotra A., Sadoshima J., et al. Downregulation of MiR-199a derepresses hypoxia-inducible factor-1α and sirtuin 1 and recapitulates hypoxia preconditioning in cardiac myocytes. Circ Res 104 (2009) 879-886
13. Laemmle A., Vorburger S., Keogh A., Roh V., Candinas D., and Stroka D. Targeting the histone deacetylase-sirt1 for anti-tumor therapy: inhibition of sirt1 down-regulates hif-1. J Hepatol 48 suppl (2008) S133-S134
14. Semenza G.L. Hypoxia-inducible factor 1: control of oxygen homeostasis in health and disease. Pediatr Res 49 (2001) 614-617
15. Feldser D., Agani F., Iyer N.V., Pak B., Ferreira G., and Semenza G.L. Reciprocal positive regulation of hypoxia-inducible factor 1alpha and insulin-like growth factor 2. Cancer Res 59 (1999) 3915-3918
16. Jung Y.J., Isaacs J.S., Lee S., Trepel J., and Neckers L. IL-1beta-mediated up-regulation of HIF-1alpha via an NFkappaB/COX-2 pathway identifies HIF-1 as a critical link between inflammation and oncogenesis. FASEB J 17 (2003) 2115-2117
17. Lee K.S., Park S.J., Kim S.R., Min K.H., Jin S.M., Puri K.D., et al. Phosphoinositide 3-kinase-delta inhibitor reduces vascular permeability in a murine model of asthma. J Allergy Clin Immunol 118 (2006) 403-409
18. Lee K.S., Kim S.R., Park S.J., Park H.S., Min K.H., Jin S.M., et al. Peroxisome proliferator activated receptor-gamma modulates reactive oxygen species generation and activation of nuclear factor-kappaB and hypoxia-inducible factor 1alpha in allergic airway disease of mice. J Allergy Clin Immunol 118 (2006) 120-127
19. Lee Y.C., and Lee H.K. Vascular endothelial growth factor in patients with acute asthma. J Allergy Clin Immunol 107 (2001) 1106
20. Lee Y.C., Kwak Y.G., and Song C.H. Contribution of vascular endothelial growth factor to airway hyperresponsiveness and inflammation in a murine model of toluene diisocyanate-induced asthma. J Immunol 168 (2002) 3595-3600
21. Lee K.S., Kim S.R., Park S.J., Lee H.K., Park H.S., Min K.H., et al. Phosphatase and tensin homolog deleted on chromosome 10 (PTEN) reduces vascular endothelial growth factor expression in allergen-induced airway inflammation. Mol Pharmacol 69 (2006) 1829-1839
22. Lee K.S., Kim S.R., Park S.J., Min K.H., Lee K.Y., Choe Y.H., et al. Mast cells can mediate vascular permeability through regulation of the PI3K-HIF-1alpha-VEGF axis. Am J Respir Crit Care Med 178 (2008) 787-797
23. Lee K.S., Kim S.R., Park H.S., Park S.J., Min K.H., Lee K.Y., et al. A novel thiol compound, N-acetylcysteine amide, attenuates allergic airway disease by regulating activation of NF-kappaB and hypoxia-inducible factor-1alpha. Exp Mol Med 39 (2007) 756-768
24. Lee K.S., Park S.J., Kim S.R., Min K.H., Lee K.Y., Choe Y.H., et al. Inhibition of VEGF blocks TGF-beta1 production through a PI3K/Akt signalling pathway. Eur Respir J 31 (2008) 523-531
25. Kwak Y.G., Song C.H., Yi H.K., Hwang P.H., Kim J.S., Lee K.S., et al. Involvement of PTEN in airway hyperresponsiveness and inflammation in bronchial asthma. J Clin Invest 111 (2003) 1083-1092
26. Chauhan D., Catley L., Hideshima T., Li G., Leblanc R., Gupta D., et al. 2-Methoxyestradiol overcomes drug resistance in multiple myeloma cells. Blood 100 (2002) 2187-2194
27. Zilberberg L., Shinkaruk S., Lequin O., Rousseau B., Hagedorn M., Costa F., et al. Structure and inhibitory effects on angiogenesis and tumor development of a new vascular endothelial growth inhibitor. J Biol Chem 278 (2003) 35564-35573
28. Ferrara N., Rinaldi B., Corbi G., Conti V., Stiuso P., Boccuti S., et al. Exercise training promotes SIRT1 activity in aged rats. Rejuvenation Res 11 (2008) 139-150
29. Tournoy K.G., Kips J.C., Schou C., and Pauwels R.A. Airway eosinophilia is not a requirement for allergen-induced airway hyperresponsiveness. Clin Exp Allergy 30 (2000) 79-85
30. Cho J.Y., Miller M., Baek K.J., Han J.W., Nayar J., Lee S.Y., et al. Inhibition of airway remodeling in IL-5-deficient mice. J Clin Invest 113 (2004) 551-560
31. Takeda K., Hamelmann E., Joetham A., Shultz L.D., Larsen G.L., Irvin C.G., et al. Development of eosinophilic airway inflammation and airway hyperresponsiveness in mast cell-deficient mice. J Exp Med 186 (1997) 449-454
32. Kay A.B. Asthma and inflammation. J Allergy Clin Immunol 87 (1991) 893-910
33. Holgate S.T., Lackie P., Wilson S., Roche W., and Davies D. Bronchial epithelium as a key regulator of airway allergen sensitization and remodeling in asthma. Am J Respir Crit Care Med 162 suppl (2000) S113-S117
34. D'Ambrosio D., Mariani M., Panina-Bordignon P., and Sinigaglia F. Chemokines and their receptors guiding T lymphocyte recruitment in lung inflammation. Am J Respir Crit Care Med 164 (2001) 1266-1275
35. Barnes P.J., Chung K.F., and Page C.P. Inflammatory mediators of asthma: an update. Pharmacol Rev 50 (1998) 515-596
36. Allegra P., Sterner R., Clayton D.F., and Allfrey V.G. Affinity chromatographic purification of nucleosomes containing transcriptionally active DNA sequences. J Mol Biol 196 (1987) 379-388
37. Hebbes T.R., Thorne A.W., and Crane-Robinson C. A direct link between core histone acetylation and transcriptionally active chromatin. EMBO J 7 (1988) 1395-1402
38. Tazi J., and Bird A. Alternative chromatin structure at CpG islands. Cell 60 (1990) 909-920
39. Roth S.Y., and Allis C.D. Histone acetylation and chromatin assembly: a single escort, multiple dances?. Cell 87 (1996) 5-8
40. Pazin M.J., and Kadonaga J.T. What's up and down with histone deacetylation and transcription?. Cell 89 (1997) 325-328
41. Wade P.A., Pruss D., and Wolffe A.P. Histone acetylation: chromatin in action. Trends Biochem Sci 22 (1997) 128-132
42. Kaeberlein M., McVey M., and Guarente L. The SIR2/3/4 complex and SIR2 alone promote longevity in Saccharomyces cerevisiae by two different mechanisms. Genes Dev 13 (1999) 2570-2580
43. Tissenbaum H.A., and Guarente L. Increased dosage of a sir-2 gene extends lifespan in Caenorhabditis elegans. Nature 410 (2001) 227-230
44. Dryden S.C., Nahhas F.A., Nowak J.E., Goustin A.S., and Tainsky M.A. Role for human SIRT2 NAD-dependent deactivity in control of mitotic exit in the cell cycle. Mol Cell Biol 23 (2003) 3173-3185
45. Starai V.J., and Escalante-Semerena J.C. Identification of the protein acetyltransferase (Pat) enzyme that acetylates acetyl-CoA synthetase in Salmonella enterica. J Mol Biol 340 (2004) 1005-1012
46. Wang G.L., and Semenza G.L. Purification and characterization of hypoxia-inducible factor 1. J Biol Chem 270 (1995) 1230-1237
47. Brahimi-Horn C., Mazure N., and Pouyssegur J. Signalling via the hypoxia-inducible factor-1alpha requires multiple posttranslational modifications. Cell Signal 17 (2005) 1-9
48. Jeong J.W., Bae M.K., Ahn M.Y., Kim S.H., Sohn T.K., Bae M.H., et al. Regulation and destabilization of HIF-1alpha by ARD1-mediated acetylation. Cell 111 (2002) 709-720
49. Gradin K., Toftgard R., Poellinger L., and Berghard A. Repression of dioxin signal transduction in fibroblasts. Identification of a putative repressor associated with Arnt. J Biol Chem 274 (1999) 13511-13518
50. Semenza G.L. Regulation of mammalian O2 homeostasis by hypoxia-inducible factor 1. Annu Rev Cell Dev Biol 15 (1999) 551-578
51. Kirsch C.M., Brokaw J.J., Prow D.M., and White G.W. Mechanism of platelet activating factor-induced vascular leakage in the rat trachea. Exp Lung Res 18 (1992) 447-459
52. Tamaoki J., Yamawaki I., Tagaya E., Kondo M., Aoshiba K., Nakata J., et al. Effect of azelastine on platelet-activating factor-induced microvascular leakage in rat airways. Am J Physiol Lung Cell Mol Physiol 276 (1999) L351-L357
53. Dvorak H.F., Brown L.F., Detmar M., and Dvorak A.M. Vascular permeability factor/vascular endothelial growth factor, microvascular hyperpermeability, and angiogenesis. Am J Pathol 146 (1995) 1029-1039
54. Lee C.G., Link H., Baluk P., Homer R.J., Chapoval S., Bhandari V., et al. Vascular endothelial growth factor (VEGF) induces remodeling and enhances TH2-mediated sensitization and inflammation in the lung. Nat Med 10 (2004) 1095-1103
55. Duan W., Aguinaldo Datiles A.M., Leung B.P., Vlahos C.J., and Wong W.S. An anti-inflammatory role for a phosphoinositide 3-kinase inhibitor LY294002 in a mouse asthma model. Int Immunopharmacol 5 (2005) 495-502
56. Zhong H., Chiles K., Feldser D., Laughner E., Hanrahan C., Georgescu M.M., et al. Modulation of hypoxia-inducible factor 1alpha expression by the epidermal growth factor/phosphatidylinositol 3-kinase/PTEN/AKT/FRAP pathway in human prostate cancer cells: implications for tumor angiogenesis and therapeutics. Cancer Res 60 (2000) 1541-1545
57. Semenza G.L. Signal transduction to hypoxia-inducible factor 1. Biochem Pharmacol 64 (2002) 993-998
58. Treins C., Giorgetti-Peraldi S., Murdaca J., Semenza G.L., and Van Obberghen E. Insulin stimulates hypoxia-inducible factor 1 through a phosphatidylinositol 3-kinase/target of rapamycin-dependent signaling pathway. J Biol Chem 277 (2002) 27975-27981
59. Kwon H.S., and Ott M. The ups and downs of SIRT1. Trends Biochem Sci 33 (2008) 517-525
60. Tanno M., Sakamoto J., Miura T., Shimamoto K., and Horio Y. Nucleocytoplasmic shuttling of the NAD+-dependent histone deacetylase SIRT1. J Biol Chem 282 (2007) 6823-6832
61. Nedachi T., Kadotani A., Ariga M., Katagiri H., and Kanzaki M. Ambient glucose levels qualify the potency of insulin myogenic actions by regulating SIRT1 and FoxO3a in C2C12 myocytes. Am J Physiol Endocrinol Metab 294 (2008) E668-E678